| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2006 | US20060216298 Plasmodium falciparum antigens inducing protective antibodies |
| 09/28/2006 | US20060216292 Treatment of neurodegenerative diseases |
| 09/28/2006 | US20060216291 Glycoprotein VI and uses thereof |
| 09/28/2006 | US20060216290 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (Par1) |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216287 EPH-like receptor protein tyrosine kinases |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing |
| 09/28/2006 | DE19903876B4 Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten A method for in vitro generation and accumulation of interleukin-1 receptor antagonist |
| 09/28/2006 | DE19724791B4 Thrombin hemmende Peptide, deren Verwendung und diese enthaltende pharmazeutische Zusammensetzungen Thrombin-inhibiting peptides, their use and pharmaceutical compositions containing them |
| 09/28/2006 | CA2638892A1 Recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 09/28/2006 | CA2603140A1 Use of bacillus licheniformis polypeptides in animal feed |
| 09/28/2006 | CA2602947A1 Method for protein purification comprising heat incubation in acetic acidic solution |
| 09/28/2006 | CA2602914A1 Statherin peptide and use in medicine |
| 09/28/2006 | CA2602676A1 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | CA2602375A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | CA2602143A1 Fermentation process for the production of diphtheria toxin |
| 09/28/2006 | CA2602028A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | CA2601592A1 Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| 09/28/2006 | CA2601400A1 Improvements in or relating to treatment and prevention of viral infections |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1705248A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 09/27/2006 | EP1705247A1 Dna participating in hydroxylation of macrolide compound |
| 09/27/2006 | EP1705190A2 Peptide derivatives |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705188A1 Modified KAP familiy polypeptides and their use in cosmetics |
| 09/27/2006 | EP1705187A1 Cosmetic compositions comprising KAP-polypeptides for care, strengthening, and/or repair of substrates consisting of keratin |
| 09/27/2006 | EP1705186A1 Vaccine and antibody against Dictyocaulus viviparus |
| 09/27/2006 | EP1705185A2 Reagent for the diagnosis of rheumatoid arthritis |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1705183A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/27/2006 | EP1705182A1 Antitumoral and antiviral peptides |
| 09/27/2006 | EP1704869A1 VR-2332 viral nucleotide sequence and methods of use |
| 09/27/2006 | EP1704868A1 HLA binding peptides and their uses |
| 09/27/2006 | EP1704778A1 FO66 transgenic mice that express pathogenic mutants of the sca2 gene |
| 09/27/2006 | EP1704507A2 Methods and system for the identification and charcterization of peptides and their functional relationships by use of measures of correlation |
| 09/27/2006 | EP1704243A2 Oligonucleotide compound and method for treating nidovirus infections |
| 09/27/2006 | EP1704239A1 Integrase fusion proteins and their use with integrating gene therapy |
| 09/27/2006 | EP1704234A2 Production of glucagon like peptide 2 and analogs |
| 09/27/2006 | EP1704233A2 New plasmids, their derivatives and fragments, their methods of manufacture and application |
| 09/27/2006 | EP1704167A1 A method to make a peptide-carrier conjugate with a high immunogenicity |
| 09/27/2006 | EP1704165A1 Novel glp-1 compounds |
| 09/27/2006 | EP1704164A2 Interleukin-11 fusion proteins |
| 09/27/2006 | EP1704163A1 Refolded membrane protein in monodisperse form |
| 09/27/2006 | EP1704160A2 Methods and compositions for identifying rna-binding proteins |
| 09/27/2006 | EP1703917A2 Heh4 molecules and uses thereof |
| 09/27/2006 | EP1703887A2 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 09/27/2006 | EP1664094A4 COMPOSITION FOR PROTECTING PROTEINS DEGRADATION COMPRISING SMALL HEAT SHOCK PROTEINS (sHSPs) AND METHOD OF TWO-DIMENSIONAL GEL ELECTROPHORESIS USING THE sHSPs |
| 09/27/2006 | EP1611240A4 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 09/27/2006 | EP1537136A4 Promoters for regulation of gene expression in plant roots |
| 09/27/2006 | EP1335936B1 Hypha-specific factors from candida albicans |
| 09/27/2006 | EP1307560B1 Schizophrenia related gene and protein |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1268807B1 Gene 763 of phytopathogenic fungus i magnaporthe grisea /i and use thereof for identifying fungicidal compounds |
| 09/27/2006 | EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/27/2006 | EP1012303B1 Factor x deletion mutants and analogues thereof |
| 09/27/2006 | EP1000162B1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1839203A FVII or FVIIa GLA domain variants |
| 09/27/2006 | CN1839202A Process for producing cytotoxic lymphocytes |
| 09/27/2006 | CN1839157A Antibodies against interleukin-22 and uses therefor |
| 09/27/2006 | CN1839156A Separation of polypeptides comprising a racemized amino acid |
| 09/27/2006 | CN1839155A Purification of glucagon-like peptides |
| 09/27/2006 | CN1839154A Isoforms of elF-5A: senescence-induced elF-5A; wounding-induced elF-5A; growth elF-5A; and DHS |
| 09/27/2006 | CN1839153A Oxidoreductase from pichia capsulata |
| 09/27/2006 | CN1839152A Modified i bordetella /i adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |
| 09/27/2006 | CN1839151A Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs |
| 09/27/2006 | CN1838967A Stabilized immunogenic HBc chimer particles |
| 09/27/2006 | CN1838965A Drug for cancer therapy |
| 09/27/2006 | CN1838962A Injection of bone marrow-derived cells and medium for angiogenesis |
| 09/27/2006 | CN1838954A Glycogen synthase kinase-3 inhibitors |
| 09/27/2006 | CN1837363A Disinsection gene and purpose thereof |
| 09/27/2006 | CN1837241A Interactive molecular binding domain of angiogenin and LIM protein |
| 09/27/2006 | CN1837240A Interactive molecular binding domain of angiogenin and lambda crystallin |
| 09/27/2006 | CN1837237A Recombinant human interleukin1 receptor antagon (rhIL-1ra) with low pyrogen and its high efficiency preparation process |
| 09/27/2006 | CN1837236A Polypeptide of extracellular domain of sodium pump and use in preparation of drugs for adjusting the activity of sodium pump |
| 09/27/2006 | CN1837235A P53 negative controllable molecule and genes encoding same |
| 09/27/2006 | CN1837234A Process for preparing low phytic acid rapeseed protein concentrate by using water and ethanol |
| 09/27/2006 | CN1837233A Halophilic bacteria and its immune protein and genes encoding same and use thereof |
| 09/27/2006 | CN1276975C Recombinant protein containing C-terminal fragment of plasmodium MSP-1 |
| 09/27/2006 | CN1276973C 谷丙转氨酶质控品 GPT control materials |
| 09/27/2006 | CN1276928C Cell apoptosis regulating protein related with heart failure |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112730 Inbred corn line W16090 |
| 09/26/2006 | US7112722 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells |
| 09/26/2006 | US7112718 Transgenic plants synthesizing high amylose starch |
| 09/26/2006 | US7112715 Transgenic mouse for targeted recombination mediated by modified Cre-ER |
| 09/26/2006 | US7112668 Polypeptides and nucleic acids encoded thereby |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112665 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 09/26/2006 | US7112663 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library, application to the detection of mycobacteria |
| 09/26/2006 | US7112660 Modified cytokine |
| 09/26/2006 | US7112659 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity; isolated human leptin fusion protein; for treating excess weight in an individual or animals, including modulation of and/or fat deposition |
| 09/26/2006 | US7112658 Orphanin FQ receptor polypeptides |
| 09/26/2006 | US7112657 PRO polypeptides; fusion proteins; immunoglobulins |
| 09/26/2006 | US7112655 JTT-1 protein and methods of inhibiting lymphocyte activation |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112653 Composition and method for preserving progenitor cells |
| 09/26/2006 | US7112571 Peptide Y-2 |
| 09/26/2006 | US7112569 Particularly when isolated from Streptomyces sp. KK565 deposited under Accesion NO: KCCM-10485 or encoded by a specific polynucleotide; used to treat neurodegenerative disorders like Alzheimer's disease. |